Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients
ConclusionsThe post-treatment GH level might be a predictor for ICIs treatment in AGC patients.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Hormones | Immunotherapy | Statistics | Study